| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/12/2011 | EP2271631A2 Inhibitors of protein kinases |
| 01/12/2011 | EP2183250B1 Naphthyridine derivatives as potassium channel modulators |
| 01/12/2011 | EP2173749B1 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents |
| 01/12/2011 | EP1996591B1 Spiroindolinone derivatives |
| 01/12/2011 | EP1987006B1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 01/12/2011 | EP1863819B1 Diazabicyclic aryl derivatives and their use as chinolinergic ligands at the nicotinic acetylcholine receptors |
| 01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |
| 01/12/2011 | CN1950371B Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands |
| 01/12/2011 | CN101945872A (1-azinone) -substituted pyridoindoles as mch antagonists |
| 01/12/2011 | CN101945871A Imidazo [1,2-a] pyridine compounds |
| 01/12/2011 | CN101945870A 5-anilinoimidazopyridines and methods of use |
| 01/12/2011 | CN101945869A Pyrido[2,3-b]pyrazine-8-substituted compounds and their use |
| 01/12/2011 | CN101945868A Gamma secretase modulators |
| 01/12/2011 | CN101945860A Branched compounds, organic thin films made by using the same, and organic thin film devices |
| 01/12/2011 | CN101941990A Prodrugs of piperazine and substituted piperidine antiviral agents |
| 01/12/2011 | CN101941977A Antitumoral analogs of lamellarins |
| 01/12/2011 | CN101941972A Preparation method of lanthanide sandwich-type phthalocyanine complex and application of lanthanide sandwich-type phthalocyanine complex in Li/SOC12 cell |
| 01/12/2011 | CN101941971A Method for synthesizing evodiamine |
| 01/12/2011 | CN101941970A Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 01/12/2011 | CN101941969A Preparation method of moxifloxacin hydrochloride |
| 01/12/2011 | CN101941968A Novel imidazopyridine compound ii with therapeutic effect |
| 01/12/2011 | CN101941967A Salt of 13a-(S) deoxidized tylophorinine, preparation method, pharmaceutical composition and application thereof |
| 01/12/2011 | CN101941946A Disubstituted benzene uracil peptide nucleic acid monomer and intermediate as well preparation methods and applications thereof |
| 01/12/2011 | CN101940214A Spiropiperidine derivatives for controlling pests |
| 01/12/2011 | CN101402635B Process for producing 5-chlorine-7-aza indole |
| 01/12/2011 | CN101367801B Preparation method for pyrrol-hexahydric N heterocycle hydroxyl morpholine derivants, and medical uses thereof |
| 01/12/2011 | CN101087789B Pyridine imidazoles and aza-indoles as progesterone receptor modulators |
| 01/12/2011 | CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives |
| 01/11/2011 | US7868205 N-[2-amino-5-(2-thienyl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide; antiproliferative, antiprotozoal agent; lymphoma, lung cancer, colon cancer, prostrate cancer, stomach cancer, breast cancer, leukemia |
| 01/11/2011 | US7868021 Antimicrobial quinolones, their compositions and uses |
| 01/11/2011 | US7868018 such as N [3-(2-(3-trifluoromethyl)-benzoylamino -[1,6]naphthyridin-3-yl)-2,4-dichloro-phenyl]-3-trifluoromethyl-benzamide, used as antiproliferative agents or for the treatment of autoimmune diseases and nervous system disorders |
| 01/11/2011 | US7868011 Hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant; kits |
| 01/11/2011 | US7868007 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/11/2011 | US7868002 Deazapurines and uses thereof |
| 01/11/2011 | US7867629 2,4-Diphenyl-6-(10-phenyl-anthracen-9-yl-pyrimidine; achieves elevation of luminance; excellent efficiency of light emission; long lifetime by an improvement of an electrode adhesion; durability; stability; OLED/organic light emitters |
| 01/11/2011 | CA2518740C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 01/11/2011 | CA2492138C N-phenyl-(2r,5s)dimethylpiperazine derivative |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2422054C Bicyclic heteroaromatic compounds |
| 01/11/2011 | CA2407593C Fused heteroaryl derivatives |
| 01/11/2011 | CA2385592C Benzamides and related inhibitors of factor xa |
| 01/06/2011 | WO2011002067A1 Heterocyclic compound and use thereof |
| 01/06/2011 | WO2011001212A1 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation |
| 01/06/2011 | WO2011001089A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/06/2011 | WO2011000945A2 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns |
| 01/06/2011 | WO2010122575A3 Process for the preparation of pure paliperidone |
| 01/06/2011 | WO2010118711A3 Novel helquats, their precursors and method of preparation thereof |
| 01/06/2011 | WO2010109084A3 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | WO2010000364A8 Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 01/06/2011 | US20110003853 Metalloproteinase Inhibitors |
| 01/06/2011 | US20110003848 Polymorphic Form Of A [1,2,4]Triazole[4,3-A] Pyridine Derivative For Treating Inflammatory Diseases |
| 01/06/2011 | US20110003847 Prasugrel Salts with Improved Properties |
| 01/06/2011 | US20110003846 Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate |
| 01/06/2011 | US20110003845 Substituted azabicyclic compounds and the use thereof |
| 01/06/2011 | US20110003843 Novel compounds derived from indole and pharmaceutical compositions containing them |
| 01/06/2011 | US20110003836 Pro-Neurogenic Compounds |
| 01/06/2011 | US20110003828 Prodrugs of nh-acidic compounds |
| 01/06/2011 | US20110003827 HIV protease inhibiting compounds |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003822 P2x3 receptor antagonists for treatment of pain |
| 01/06/2011 | US20110003810 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| 01/06/2011 | US20110003809 Imidazo [4,5-b] pyridine derivatives used as raf inhibitors |
| 01/06/2011 | US20110003807 Thiazole derivatives |
| 01/06/2011 | US20110003806 Heteroaryls and uses thereof |
| 01/06/2011 | US20110003802 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase |
| 01/06/2011 | US20110003799 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 01/06/2011 | US20110003798 Compounds and compositions as kinase inhibitors |
| 01/06/2011 | US20110003794 Naphthyridine Integrase Inhibitors |
| 01/06/2011 | US20110003793 AZINONE-SUBSTITUTED AZEPINO[b]INDOLE AND PYRIDO-PYRROLO-AZEPINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF |
| 01/06/2011 | US20110003790 Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors |
| 01/06/2011 | US20110003789 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| 01/06/2011 | US20110003788 Fused heterocyclic derivative and use thereof |
| 01/06/2011 | US20110003738 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003737 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003362 Conjugates of biological substances |
| 01/06/2011 | US20110003011 Fungicidal active compound combinations |
| 01/06/2011 | US20110002953 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 01/06/2011 | US20110002855 Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues |
| 01/06/2011 | US20110001129 Substituted bipyridyl compound and organic electroluminescent device |
| 01/06/2011 | CA2766967A1 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation |
| 01/06/2011 | CA2764193A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 01/05/2011 | EP2270011A1 Condensed imidazolo derivatives for the inhibition of aromatase |
| 01/05/2011 | EP2270008A1 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinases inhibitors |
| 01/05/2011 | EP2269602A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 01/05/2011 | EP2268647A2 Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders |
| 01/05/2011 | EP2268640A1 Process for preparing enantiomerically pure indolopyridines |
| 01/05/2011 | EP2268639A2 Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate |
| 01/05/2011 | EP2268638A1 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists |
| 01/05/2011 | EP2268637A1 Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors |
| 01/05/2011 | EP2268618A1 Compounds and compositions as tlr activity modulators |
| 01/05/2011 | EP1558256B1 Pyrroloquinoline quinone and a beta blocker for the treatment of ischemia or reperfusion injury |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | CN101939320A Polymorphic form |
| 01/05/2011 | CN101939315A Gamma secretase modulators |
| 01/05/2011 | CN101939312A Gamma secretase modulators |
| 01/05/2011 | CN101939311A Heterocyclic compounds with affinity to muscarinic receptors |
| 01/05/2011 | CN101939302A Mesoionic pesticides |
| 01/05/2011 | CN101939054A Organic compounds |
| 01/05/2011 | CN101935322A Diazabicyclic central nervous system active agents |
| 01/04/2011 | US7863454 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |